| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5882807 | Clinical Lymphoma Myeloma and Leukemia | 2016 | 5 Pages |
Abstract
The results of the present meta-analysis have confirmed the role of the CALR mutation in the diagnosis of, and as a prognostic tool for, PMF. Our results suggest that patients with the CALR mutation will have better overall survival than patients with the JAK2 mutation in a non-Asian population.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Hampig Raphael Kourie, Lieveke Ameye, Marianne Paesmans, Dominique Bron,